What's Hot in Gastroenterology

 
 
  • Progress Noted in Treatment of Several Common Liver Diseases Dr William Balistreri provides an overview of the latest data on such disorders as alpha-1 antitrypsin deficiency, drug-induced liver injury, and parenteral nutrition-associated cholestasis.
  • Surveying the Latest Data in Fatty Liver Disease The recent Liver Meeting featured a wealth of studies on nonalcoholic fatty liver disease and steatohepatitis. Dr William Balistreri shines a light on those most likely to affect your practice.
  • Hepatitis B Takes Center Stage Dr William Balistreri surveys hepatitis B, touching on everything from the virus' role in the European migrant crisis to the novel treatment strategies being used closer to home.
  • A Focus on Hepatitis C: Outcomes Dr William Balistreri completes his three-part series on hepatitis C with a discussion about possible outcomes and a glimpse into the future of treatment.
  • A Focus on Hepatitis C: Novel Therapeutic Regimens In the second part of this three-part series, Dr William Balistreri continues his discussion of hepatitis C with a review of new antiviral agents and novel therapeutic strategies.
  • A Focus on Hepatitis C: Cascade of Care In the first part of this three-part series on hepatitis C, Dr William Balistreri discusses the prevalence of this infection, screening methods, and access and barriers to care.
  • Unsafe at Any Lunch? In the wake of several high-profile foodborne disease outbreaks, Dr William Balistreri details the clinical consequences, possible causes, and what can be done to stop them in the future.
  • Should We All Go Gluten-Free? It is undoubtedly the major dietary trend of the decade, but is there evidence to support avoiding gluten if you don't have celiac disease?
  • Hepatitis C: 25 Years Old, and Fading A wave of new antiviral drugs and novel treatment strategies are heralding a future in which hepatitis C may be globally eradicated -- but some obstacles still remain.
  • Perinatal Transmission of the Hepatitis B Virus A young pregnant woman is HBsAg-positive. Is it possible to prevent transmission of the infection to her unborn baby?
  • HBV: React Before the Virus Does This once-fatal condition can now be easily prevented, but to screen patients appropriately requires a level of awareness that is lacking at present.
  • What's on the Horizon for Treating NASH? The obesity epidemic is invariably bringing with it an epidemic of fatty liver disease. When the time comes, what will we have available for treatment?
  • Noninvasive Alternatives to Assess Liver Fibrosis Noninvasive serum biomarkers and imaging techniques could soon replace the liver biopsy to assess fibrosis.
  • The Epidemic of Fatty Liver Disease New recommendations are available to help clinicians combat the growing problem of fatty liver disease in both adults and children.
  • Bariatric Surgery in Children: Is This the Right Approach?   As the obesity epidemic rages on, bariatric surgery is being performed in younger and younger patients. Three experts discuss the pros and cons.
  • Neodymium Magnets: Too Attractive? Children find these little supermagnets tempting to swallow, but they wreak havoc in the intestines because of their persisting magnetic attraction within the bowel.
  • Top 10 Highlights From The Liver Meeting Dr. William Balistreri shares his don't-miss picks from this year's meeting.
  • The Gut-Liver Axis and NAFLD The gut microbiota offers a new way to view disease and its treatment.
  • Speaking of Hepatitis, We Have 'A' Vaccine But how effective is it, and are we using it properly?
  • Thickening the Alphabet Soup: The Emergence of Hepatitis E Everything you never knew about hepatitis E.